<sentence id="0">The cheB2 Mutant Shows Reduced Virulence in Mice</sentence>
<sentence id="1">We further tested the virulence of the cheB2 mutant TB0173s in a mouse model of lung infection , utilizing the view-controlled intratracheal infection protocol [ 48 ] .</sentence>
<sentence id="2">Ten female C3H/HeN mice each were inoculated with 7.5x106 CFU equivalent to the LD50 dose of the wild type strain determined in prior experiments <scope type="neg" id="0">( data <cue type="neg" id="0">not</cue> shown )</scope> .</sentence>
<sentence id="3">Figure 4 displays the representative outcome of one of three independent infection experiments .</sentence>
<sentence id="4">The cheB2 mutant ( TB0173s ) showed a significantly attenuated virulence during respiratory tract infection of mice as compared to the parental strain TB and the complemented strain TB0173sp2B2 .</sentence>
<sentence id="5">Infection with the wild type resulted in 50 % dead animals ( 5 of 10 ) by day 5 compared to 10 % deaths for the TB0173s cheB2 mutant ( 1 of 10 ; P=0.036 , Fisher 's exact test ) .</sentence>
<sentence id="6">Infection with the complemented strain TB0173sp2B2 resulted in 60 % dead by day 3 ( 6 of 10 ; P=0,0018 , Fisher 's exact test ) ( Figure 4A ) .</sentence>
<sentence id="7">We have also evaluated the body condition of the mice during bacterial infection ( see Materials and Methods ) .</sentence>
<sentence id="8">Surviving mice infected with the cheB2 mutant showed a significantly less troubled body condition from days 3 to 6 post infection ( P<0.01 , Mann-Whitney rank test ) than surviving mice infected with the wild type strain <scope type="spec" id="1"> <cue type="spec" id="1">indicating that</cue> the former group recovered earlier than the latter ( Figure 4B )</scope> .</sentence>